BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zheng SZ, Liu DJ, Sun P, Yu GS, Xu YT, Gong W, Liu J. Feasibility and safety of sorafenib treatment in hepatocellular carcinoma patients with spontaneous rupture. World J Gastroenterol 2014; 20(43): 16275-16281 [PMID: 25473183 DOI: 10.3748/wjg.v20.i43.16275]
URL: https://www.wjgnet.com/1007-9327/full/v20/i43/16275.htm
Number Citing Articles
1
Kuo-Shyang Jeng, Chun-Chieh Huang, Chien-Chu Lin, Cheng-Kuan Lin, Chung-Jen Teng, Kuo-Hsin Chen. Liver Transplantation After Downstagings of Ruptured Advanced Hepatocellular Carcinoma in Cirrhotic Liver: Is It Advisable? A Case ReportTransplantation Proceedings 2019; 51(5): 1468 doi: 10.1016/j.transproceed.2019.01.125
2
Marta Romero-Gutiérrez, Sonia Pascual, Laura Márquez, Mariano Gómez-Rubio, Mireia Miquel, Cristina Alarcón, Teresa Ferrer, Carles Aracil, Diana Horta, Raquel Latorre, Jesús González Santiago, Vanesa Bernal, Cristina Fernández, Belén Piqueras, María Luisa Gutiérrez, Ana Martín, Julia Morillas, Dalia Morales, Sonia Blanco, Paloma Rendón, Inmaculada Chico, Milagros Testillano, Carolina Delgado, Ana Matilla, Rafael Gómez Rodríguez. Spontaneously ruptured hepatocellular carcinoma on non-cirrhotic liver: A prospective case seriesGastroenterología y Hepatología 2023;  doi: 10.1016/j.gastrohep.2023.08.008
3
Zhoujing Cheng, Lin He, Yingjie Guo, Yuhua Song, Shasha Song, Lijiu Zhang. The combination therapy of transarterial chemoembolisation and sorafenib is the preferred palliative treatment for advanced hepatocellular carcinoma patients: a meta-analysisWorld Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-02017-0
4
Wen‐Hui Chan, Chien‐Fu Hung, Kuang‐Tse Pan, Kar‐Wai Lui, Yu‐Ting Huang, Shen‐Yen Lin, Yang‐Yu Lin, Tsung‐Han Wu, Ming‐Chin Yu. Impact of spontaneous tumor rupture on prognosis of patients with T4 hepatocellular carcinomaJournal of Surgical Oncology 2016; 113(7): 789 doi: 10.1002/jso.24245
5
Tetsu Tomonari, Yasushi Sato, Hironori Tanaka, Takahiro Tanaka, Tatsuya Taniguchi, Masahiro Sogabe, Koichi Okamoto, Hiroshi Miyamoto, Naoki Muguruma, Yu Saito, Satoru Imura, Yoshimi Bando, Mitsuo Shimada, Tetsuji Takayama. Conversion therapy for unresectable hepatocellular carcinoma after lenvatinibMedicine 2020; 99(42): e22782 doi: 10.1097/MD.0000000000022782
6
Xiaozhun Huang, Chenyang Jia, Lin Xu, Xinyu Bi, Fengyong Lai, Zhangkan Huang, Xiaoqing Li, Xin Yin, Yong Ni, Xu Che. Survival of Patients Subjected to Hepatectomy After Spontaneous Rupture of Hepatocellular Carcinoma: A Meta-analysis of High-quality Propensity Score Matching StudiesFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.877091
7
Lei Xu, Lin Chen, Wei Zhang. Neoadjuvant treatment strategies for hepatocellular carcinomaWorld Journal of Gastrointestinal Surgery 2021; 13(12): 1550-1566 doi: 10.4240/wjgs.v13.i12.1550
8
Shun Tang, Minmin Wang, Yuhui Peng, Yuanjing Liang, Jiarong Lei, Qiu Tao, Tianqi Ming, Yanqiao Shen, Chuantao Zhang, Jinlin Guo, Haibo Xu. Armeniacae semen amarum: a review on its botany, phytochemistry, pharmacology, clinical application, toxicology and pharmacokineticsFrontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1290888
9
Chunling Wang, Xiaozhun Huang, Xiaofeng Lan, Dongmei Lan, Zhangkan Huang, Shu Ye, Yihong Ran, Xinyu Bi, Jianguo Zhou, Xu Che. Research progress of spontaneous ruptured hepatocellular carcinoma: Systematic review and meta-analysisFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.973857
10
Demetrios Moris, Jeffery Chakedis, Steven H. Sun, Gaya Spolverato, Diamantis I. Tsilimigras, Ioannis Ntanasis‐Stathopoulos, Eleftherios Spartalis, Timothy M. Pawlik. Management, outcomes, and prognostic factors of ruptured hepatocellular carcinoma: A systematic reviewJournal of Surgical Oncology 2018; 117(3): 341 doi: 10.1002/jso.24869